Form 8-K/A - Vidacann Closing true 0001813452 0001813452 2024-05-10 2024-05-10
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K/A
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 10, 2024
 
PLANET 13 HOLDINGS INC.
(Exact name of registrant as specified in its charter)
 
Nevada
 
000-56374
 
83-2787199
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification Number)
 
2548 West Desert Inn Road, Suite 100
Las Vegas, Nevada
 
89109
(Address of principal executive offices)
 
(Zip Code) 
 
(702) 815-1313
(Registrants telephone number, including area code)      
 
Not applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.424)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act: None
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 


 
1

 
Item 2.01 Completion of Acquisition or Disposition of Assets.
 
On May 14, 2024, Planet 13 Holdings Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Filing”) reporting the completion of its acquisition of all of the membership interests in VidaCann, LLC (“VidaCann”). This amendment amends the Original Filing to include financial statements of VidaCann required by Item 9.01(a) and pro forma financial statements of the Company required by Item 9.01(b).
 
Item 9.01 Financial Statements and Exhibits.
 
(a) Financial Statements of businesses or funds acquired.
 
The audited financial statements of VidaCann as of and for the fiscal year ended December 31, 2023 are filed as Exhibit 99.1 and incorporated into this Item 9.01(a). The unaudited financial statements of VidaCann as of March 31, 2024 and for the three months ended March 31, 2024, and the notes related thereto, are filed as Exhibit 99.2 and incorporated into this Item 9.01(a). The audited financial statements of VidaCann as of and for the fiscal year ended December 31, 2022 were filed as Exhibits 99.4 of the Company’s Current Report on Form 8-K, filed on March 4, 2024, and are incorporated into this Item 9.01(a).
 
(b) Pro forma financial information.
 
The unaudited pro forma condensed combined balance sheet as of March 31, 2024 and the unaudited pro forma condensed combined statements of operations and comprehensive income for the three months ended March 31, 2024 and for the year ended December 31, 2023 are filed as Exhibit 99.4 and incorporated into this Item 9.01(b).
 
(d) Exhibits
 
        Incorporated by Reference    
Exhibit No.   Description   Form   Exhibit   Filing Date   Filed/Furnished Herewith
23.1   Consent of Masters, Smith & Wisby, P.A. (VidaCann 2022).   8-K   23.2   03/04/2024    
23.2   Consent of Masters, Smith & Wisby, P.A. (VidaCann 2023).              
99.1   Audited financial statements of VidaCann, LLC as of December 31, 2023 and for the year ended December 31, 2023, and the notes related thereto.              
99.2   Unaudited financial statements of VidaCann, LLC as of March 31, 2024 and for the three months ended March 31, 2024, and the notes related thereto.              
99.3   Audited financial statements of VidaCann, LLC as of December 31, 2022 and for the year ended December 31, 2022, and the notes related thereto.   8-K   99.4   03/04/2024    
99.4   Unaudited Pro Forma Consolidated Financial Statements.              
104   Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.                
 
 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Planet 13 Holdings Inc.
 
       
Date: July 24, 2024
By:
/s/ Robert Groesbeck
 
 
Name
Robert Groesbeck
 
 
Its:
Co-Chief Executive Officer
 
       
Date: July 24, 2024
By:
/s/ Larry Scheffler
 
 
Name:
Larry Scheffler
 
 
Its:
Co-Chief Executive Officer
 
 
3

Exhibit 23.1

 

CONSENT OF INDEPENDENT AUDITORS

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-274829) and Form S-8 (No. 333-264140 and No. 333-274566) of Planet 13 Holdings Inc. of our report dated April 15, 2024, relating to the financial statements of VidaCann LLC for the year ended December 31, 2023 appearing in this Current Report on Form 8-K dated July 24, 2024.

 

/s/ Masters, Smith & Wisby, P.A.

 

Jacksonville, Florida

July 24, 2024

 

 

Exhibit 99.1

 

 

 

 

 

 

 

 

 

 

 

Financial Statements

 

VIDACANN, LLC

   
   

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ex_632134img001.jpg

 

 

 

 

 

 

 

 

 

TABLE OF CONTENTS

       
       
     

Page

     

Number

       
       

INDEPENDENT AUDITOR'S REPORT

 

1-2

       
       

FINANCIAL STATEMENTS

   
       
 

Balance Sheet

 

3

       
 

Statement of Income

 

4

       
 

Statement of Changes in Members' Equity

 

5

       
 

Statement of Cash Flows

 

6

       
       

NOTES TO FINANCIAL STATEMENTS

 

7 - 13

 

 

 

 

 
ex_632134img001.jpg

Steven D. Rawlins, CPA

Gary M. Huggett, CPA

David W. Howie, CPA

INDEPENDENT AUDITOR'S REPORT

 

To Management and the Members

Vidacann, LLC

Jacksonville, Florida

 

Opinion

 

We have audited the accompanying financial statements of Vidacann, LLC., which comprise the balance sheet as of December 31, 2023, and the related statement of income, changes in members equity, and cash flows for the year then ended, and the related notes to the financial statements.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Vidacann, LLC. as of December 31, 2023, and the results of its operations and its cash flows for the year then ended in accordance with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of Vidacann, LLC. and to meet our other ethical responsibilities in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

 

Responsibilities of Management for the Financial Statements

 

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Vidacann, LLC.’s ability to continue as a going concern within one year after the date that the financial statements are available to be issued.

 

Auditors Responsibilities for the Audit of the Financial Statements

 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with generally accepted auditing standards will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements, including omissions, are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

 

 

Jacksonville Office

4651 Salisbury Road, Suite 185

Jacksonville, FL 32256

P 904.396.2202 F 904.398.1315

www.mswcpa.com

 

 

 

1

Ponte Verda Office

822 A1A North, Suite 310

Ponte Vedra Beach, FL 32082

P 904.280.5400 F 904.247.1665

www.mswcpa.com

Members of the American and Florida Institutes of Certified Public Accountants

 

 

 

In performing an audit in accordance with generally accepted auditing standards, we:

 

 

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

 

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

 

 

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of Vidacann, LLC.’s internal control. Accordingly, no such opinion is expressed.

 

 

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

 

 

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about Vidacann, LLC.’s ability to continue as a going concern for a reasonable period of time.

 

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.

 

/s/ Masters, Smith & Wisby P.A.

 

Certified Public Accountants

 

Jacksonville, Florida

 

April 15, 2024

 
 

 

 

2

 

VIDACANN, LLC.

 

BALANCE SHEET

December 31, 2023

 

ASSETS

 
         

Current Assets:

       

Cash and cash equivalents

  $ 2,477,687  

Inventory

    5,351,599  

Capitalized cultivation costs

    1,985,854  

Prepaid expenses

    124,056  

Total Current Assets

    9,939,196  
         

Property and Equipment:

       

Leasehold improvements

    14,731,111  

Machinery, equipment and vehicles

    6,625,701  

Furniture and fixtures

    523,072  

Computer equipment and software

    271,796  

Construction in progress

    74,682  
      22,226,362  

Accumulated depreciation

    (4,693,044 )

Total Property and Equipment

    17,533,318  
         

Other Assets:

       

Operating lease right-of-use assets

    20,874,473  

Intangible assets - net

    81,081  

Deposits and other assets

    386,722  

Total Other Assets

    21,342,276  
         

Total Assets

  $ 48,814,790  
         

LIABILITIES AND MEMBERS' EQUITY

 
         

Current Liabilities:

       

Accounts payable

  $ 689,115  

Accrued expenses

    357,795  

Line of credit

    2,979,742  

Current portion of long-term debt

    74,339  

Current portion of operating lease liabilities

    4,107,362  

Total Current Liabilities

    8,208,353  
         

Long-Term Liabilities:

       

Long-term debt

    110,629  

Operating lease liabilities, less current portion

    16,950,911  

Due to investors

    2,194,481  

Total Long-Term Liabilities

    19,256,021  
         

Total Liabilities

    27,464,374  
         

Members' Equity

    21,350,416  
         

Total Liabilities and Members' Equity

  $ 48,814,790  

 

See Accompanying Notes to the Financial Statements

 

3

 

VIDACANN, LLC

 

STATEMENT OF INCOME

Year Ended December 31, 2023

 

Net Sales

  $ 34,263,343  
         

Cost of Goods Sold

    21,688,917  
         

Gross Profit

    12,574,426  
         
         

Selling, General and Administrative Expenses:

       

Salaries, wages and related payroll expenses

    14,830,186  

Rent

    4,229,636  

Cultivation/branding fees

    878,738  

Packaging and supplies

    4,766,280  

Advertising

    398,955  

Automobile

    234,577  

Depreciation

    1,270,563  

Employee benefits

    491,748  

Contributions

    3,025  

Commissions

    262,184  

Insurance

    673,332  

Outside services

    237,255  

Professional fees

    604,374  

License and permits

    71,908  

Office expense

    781,763  

Taxes

    147,372  

Amortization

    17,186  

Retail expense

    77,416  

Product testing

    830,856  
Royalties     4,721  

Travel

    152,501  

Utilities

    1,014,368  

Repairs

    638,425  
         

Total Selling, General and Administrative Expenses

    32,617,369  
         

Applied overhead costs

    (19,706,192 )
         

Operating Loss

    (336,751 )
         

Other Income (Expense):

       
Employee retention credit refund, net     2,798,264  
Regulatory assessments     (401,500 )

Loss on sale of property and equipment and discontinued operations

    (69,837 )
Interest expense     (537,774 )

Other income, net

    50,000  
         

Net Income

  $ 1,502,402  

 

See Accompanying Notes to the Financial Statements

 

4

 

VIDACANN, LLC

 

STATEMENT OF CHANGES IN MEMBERS' EQUITY

 

           

Loop's

   

Ray of

         
   

Loop's

   

Nursery &

   

Hope 4

         
   

Dispensaries

   

Greenhouses

   

Florida

         
   

LLC - 74%

   

Inc. - 1%

   

LLC - 25%

   

Total

 
                                 
                                 

Balances at January 1, 2023

  $ 14,146,117     $ 1,952,593     $ 3,749,304     $ 19,848,014  
                                 

Net income

    1,111,777       15,024       375,601       1,502,402  
                                 

Balances at December 31, 2023

  $ 15,257,894     $ 1,967,617     $ 4,124,905     $ 21,350,416  

 

See Accompanying Notes to the Financial Statements

 

5

 

VIDACANN, LLC

 

STATEMENT OF CASH FLOWS

Year Ended December 31, 2023

 

Cash Flows from Operating Activities:

       

Net Income

  $ 1,502,402  

Adjustments to reconcile net income to net cash provided by operating activities:

       

Depreciation

    1,270,563  

Amortization

    17,186  
Loss on disposal of property and equipment     54,838  

(Increase) decrease in:

       

Inventory

    (852,935 )

Cultivation costs

    575,741  

Prepaid expenses

    5,032  

Other assets

    358,395  
Net operating lease liability     (348,145 )

Increase (decrease) in:

       

Accounts payable

    253,131  

Accrued expenses

    60,389  
         

Net cash provided by operating activities

    2,896,597  
         

Cash Flows From Investing Activities:

       
Proceeds from sale of property and equipment     4,800  

Purchase of property and equipment

    (494,399 )
         

Net cash used by investing activities

    (494,399 )
         

Cash Flows from Financing Activities:

       

Repayment of long-term debt

    (69,860 )

Repayment to investors

    (1,376,816 )
         

Net cash provided by financing activities

    (1,446,676 )
         

Net Increase in Cash and Cash Equivalents

    955,522  
         

Cash and Cash Equivalents at Beginning of Year

    1,522,165  
         

Cash and Cash Equivalents at End of Year

  $ 2,477,687  
         

Supplemental Disclosure of Cash Flow Information:

       

Cash paid during the year for interest

  $ 537,774  
         

Non-Cash Investing and Financing Information:

       

Equipment acquired through note payable

  $ 202,757  

 

See Accompanying Notes to the Financial Statements

 

6

 

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

Year Ended December 31, 2023

 

A.         Summary of Significant Accounting Policies:

 

Nature of Business

 

Vidacann, LLC (the “Company”) d/b/a VidaCann is a limited liability corporation formed on June 13, 2019 and is the successor to Vidacann, Ltd. which was formed on September 5, 2017 and dissolved on June 13, 2019. The Company is licensed in the State of Florida as a Medical Marijuana Treatment Center under Florida Statue 381.986. The Company maintains cultivation facilities located in Jacksonville, FL and a manufacturing complex also located in Jacksonville. The Company operates 27 dispensaries located throughout the state of Florida.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, cash equivalents include time deposits, certificates of deposit and all highly liquid instruments with original maturities of three months or less. No such instruments were held at December 31, 2023.

 

Fair Value of Financial Instruments

 

The carrying amounts of cash, accounts receivable, other current assets, accounts payable, accrued liabilities, and notes payable approximate fair value because of the short maturity of those instruments.

 

Inventory

 

Inventories are stated at the lower of cost or net realizable value based on their estimated value in the process from seed to finished product. Inventories of harvested plants are transferred from cultivation costs at an estimated cost based on the value of distilled oils. As the plants are processed into distilled oils, they are revalued to reflect the value added in the distillation process. A final revaluation is made as the oils are manufactured into the finished product. Unused packaging and hardware are initially valued at cost, less any reserves for obsolescence. All inventories are determined on the first in first out (“FIFO”) method of accounting.

 

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is provided principally using the straight-line method based on the following estimated useful lives of the assets:

 

 

Years

Leasehold improvements

40

Machinery and equipment

10

Vehicles

10

Furniture and fixtures

5-10

Computer equipment and software

3-10

`

Depreciation expense was $1,270,563 for the year ended December 31, 2023.

 

Expenditures for maintenance and repairs are charged to operations, while renewals and betterments are capitalized. The cost and associated accumulated depreciation of assets retired or disposed of are removed from the records and any resulting gain or loss is included in income.

 

7

 

 

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

Year Ended December 31, 2023

 

A.         Summary of Significant Accounting Policies (continued):

 

Capitalized Cultivation Costs

 

The Company has adopted FASB ACC 905 “Agricultural Producers and Agricultural Cooperatives”, which prescribes that all direct and indirect costs of growing crops be capitalized and reported at the lower of cost or net realizable value.

 

Intangible Assets

 

The Company has adopted FASB ASC 350, “Intangibles-Goodwill and Other.” This statement requires that an intangible asset with a definite life be amortized over that life in a pattern that reflects the use or consumption of the asset’s economic benefits. Intangible assets consist primarily of a licensing agreement and capitalized software costs totaling $134,727. The accumulated amortization for these assets was $53,646 at December 31, 2023. For those assets that have no definite useful life, however, no amortization is to be recorded until the remaining useful life is no longer indefinite. Intangible assets that are thus not subject to amortization should be analyzed annually to determine if there has been an impairment of the asset’s value, i.e., whether future economic benefits associated with that asset are less than its current recorded value. If necessary, an impairment loss would then be recognized to reduce the asset’s carrying value to its current fair value.

 

Leases:

 

In February 2016, the FASB issued ASU No. 2016-02 Leases (Topic 842). This guidance amends existing lease standards requiring lessees to recognize a liability for what were previously defined as operating leases, an off-balance sheet item, on their balance sheets with a corresponding right to use asset. The Company adopted the requirements of the guidance effective January 1, 2022 and has elected to apply the provisions of this standard to the beginning of the period of adoption. 

 

The lease liability is initially and subsequently recognized based on the present value of its future lease payments. The discount rate used is the U.S. Treasury par yield curve rate based on the information available at the commencement date for all leases. The right-to-use asset is subsequently measured throughout the lease term at the amount of the remeasured lease liability. Lease cost for lease payments is recognized on a straight-line basis over the lease term.

 

The Company has elected, for all underlying classes of assets, to not recognize right-to-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less at lease commencement, and do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise. The Company recognizes lease cost associated with short-term leases on a straight-line basis over the lease term.

 

Revenue Recognition

 

The Company has adopted Financial Accounting Standards Board (FASB) ASU 2014-09 Revenue from Contracts with Customers. This ASU establishes a uniform 5-step (performance obligations) process to ensure that revenues are recognized when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods and services. The standard also distinguishes the timing of revenues of those transferred at a point in time and those that are transferred over time.

 

8

 

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

Year Ended December 31, 2023

 

A.         Summary of Significant Accounting Policies (continued):

 

The Company adopted the standard using the modified retrospective approach as allowed under the standard which allows only contracts not completed as of the date of adoption, with no restatement of comparative periods. Management has determined that the adoption of ASU 2014-09 has not significantly altered the way revenue is recognized for the Company.

 

The company generates all its revenue from retail sales of its medical marijuana products in the State of Florida to licensed patients via its retail dispensaries. The performance obligations of these sales are satisfied at a point in time when the customer transfers the transaction price to the Company and the customer receives the product.

 

Advertising and Promotion

 

Advertising and promotion costs are charged to operations when incurred. For the year ended December 31, 2023, the total cost of advertising and promotion charged to operations was $398,955.

 

Income Taxes

 

The Company reports to its members their proportionate share of its modified cash basis income or loss for each tax year, with the members including that income or loss in their respective income tax returns. The Company itself is not a taxpaying entity for federal or state income tax purposes and accordingly, no income taxes have been recorded in these financial statements. The Company takes certain tax positions which it believes are adhering to the laws established by the taxing authorities taking into consideration IRS Section 280E rules. The Company doesn’t believe it has taken any uncertain tax positions which could subject it to penalties or interest; therefore, none have been accrued in the accompanying financial statements.

 

Use of Management Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as revenue and expenses recognized during the period reported, actual results could differ from those estimates.

 

Subsequent Events

 

The Company has evaluated subsequent events through the date of the independent auditor's report, which is the date the financial statements were available to be issued.

 

B.         Inventory:

 

Inventory at December 31, 2023 consisted of the following:

 

Finish product - lab

 

 $ 2,622,300

Finish product-dispensaries

 

2,033,173

Packaging and supplies

 

696,126

     

Total Inventory

    

$ 5,351,599

 

9

 

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

Year Ended December 31, 2023

 

C.         Notes Payable:

 

Notes payable consist of the following:

 

       

2023

Notes payable to equipment finance company, payable in monthly payments of $6,400 of principle and interest at 8.49%, secured by related equipment, maturing May 2026

 

   

 

 $ 162,148

         

Notes payable to equipment finance company, payable in monthly payments of $1,976 of principle and interest at 0%, secured by related equipment, maturities through July 2026

     

22,820

       

184,968

Less current obligation

     

(74,339)

         

Note payable, net of current portion

 

    

 

$ 110,629

 

Maturities of principal payment and the notes payable are as follows:

 

2024

74,339

2025

78,771

2026

31,858

 

$ 184,968

 

D.         Concentrations:

 

The Company is limited by Florida law to retail customers residing in the State of Florida who have a valid medical marijuana certificate.

 

E.         Lease Commitments:

 

The Company leases dispensary, cultivating, manufacturing facilities and vehicles under operating leases expiring in various years through 2029. The components of lease cost for the year ended December 31, 2023 are as follows:

 

Operating lease cost -buildings

 $ 4,229,636

Operating lease costs – vehicles

104,438

 

 

Total Lease Cost

$ 4,334,074

 

Amounts reported in the consolidated balance sheet as of December 31, 2023 were as follows:

 

Operating lease ROU assets

 $ 20,874,473

   

Current portion of operating lease liability

$   4,107,362

 

 

Long-term portion of operating lease liability

$ 16,950,911

 

10

 

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

Year Ended December 31, 2023

 

E.         Lease Commitments (continued):

 

Other information related to leases as of December 31, 2023 was as follows:

 

Supplemental cash flow information:    
Cash paid for amounts included in the measurement of lease liabilities: 

Operating cash flow from operating lease

 

 $ 4,334,074

     
ROU assets obtained in exchange for lease obligations 

Operating leases

 

$ 1,524,185

 

 

 

Weighted average remaining lease term:
Operating leases   5.06 years
     
Weighted average discount rate: 
Operating leases   1.29%

 

Maturities of lease liabilities under noncancelable orating leases as of December 31, 2023 are as follows:

 

2024

$   4,314,218

2025

4,042,094

2026

3,880,383

2027 3,816,919
2028 3,173,593

Thereafter

2,591,072

Total undiscounted leases 21,818,279
Less inputted interest (760,006)
   

Total

$ 21,058,273

 

F.           Line of Credit:

 

The Company has a bank line of credit available for a total of $3,000,000 secured by a blanket lien on business assets. This line of credit requires monthly interest payments at the WSJ Prime Rate plus 1.5% (10.00% at December 31, 2023). The line of credit is payable on demand and expires February 20, 2025.

 

G.           Related Party Transactions:

 

Due to Investors

 

The Company had amounts due to several investors totaling $1,376,817, with interest of 7.5% payable monthly These notes were paid off in the 3rd quarter of the year ended December 31, 2023. 

 

11

 

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

Year Ended December 31, 2023

 

G.           Related Party Transactions (continued):

 

The Company has amounts due to three investors totaling $2,194,481, with interest ranging from 7.5% to 10% payable monthly. As repayment is not expected within the year they have been classified as long-term on the balance sheet.

 

Purchases

 

The Company’s vendor for certain packaging supplies is owned by an investor. The Company incurred expenses of $227,617 with this vendor for the year ended December 31, 2023.

 

Cultivation facility/land lease

 

In May of 2020, the Company entered into a land lease agreement for its cultivation facility with a member which calls for rent of $300,000 per year, per greenhouse not to exceed $4,000,000 per year. This agreement expires on December 31, 2029 with renewal options for two successive periods of five years each. During 2023, the Company operated 8 greenhouses the minimum rent payments for seven greenhouses are included in the schedule of lease payments at Note E.

 

Manufacturing facility lease

 

The Company leases its manufacturing facility under a ten -year lease agreement with an investor expiring on April 30, 2028. The initial base rent of $126,000 per year, plus additional amounts for insurance, taxes and common area maintenance and base rent increases of 3% per year. Rent expense related to this lease was $144,292 for the year ended December 31, 2023. Future minimum lease payments are included in the schedule of lease payments at Note E.

 

H.         Concentrations of Credit Risk:

 

Cash balances are exposed to credit risk since the company periodically maintains balances in excess of FDIC insurance limits. The Company maintains its cash balances at a high-quality financial institution and does not believe it is exposed to any significant risk with respect to these cash balances. At December 31, 2023 cash balances exceed FDIC insured limits by $1,196,366.

 

I.           Retirement Plan

 

The Company has adopted a qualified 401(k) deferred compensation plan. Employees meeting certain eligibility requirements can participate in the plan by making elective salary deferrals up IRS limits. The plan provides for discretionary employer contributions as determined by management. The Company did not make any elective contributions to the plan for the years ended December 31, 2023.

 

J.           Subsequent Events

 

Under the provisions of the Coronavirus Aid, Relief, and Economic Security act (the “CARES Act”) the Company became eligible for a refund of certain payroll taxes paid. The Company has applied for and received a refund of $3,299,022 and incurred related expenses of $450,758.

 

12

 

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

Year Ended December 31, 2023

 

K.           Membership Interest Purchase Agreement

 

On August 28, 2023, the Company and its members (the “Sellers”) entered into a Membership Interest Purchase Agreement (“Purchase Agreement”) with Planet 13 Holdings, Inc. (Planet 13) pursuant to which, upon the terms and subject to the conditions, Planet 13 will acquire from the Sellers all of the membership interests in VidaCann.

 

Pursuant to the Purchase Agreement, Planet 13 will acquire VidaCann from the Sellers for agreed consideration at closing of the transaction (the “Closing”) equal to the sum of: (i) 78,461,538 shares of common stock of Planet 13 (the “Base Share Consideration”), of which 1,307,698 shares will be issued to VidaCann’s industry advisor (the “VC Advisor”); (ii) a cash payment of US$4,000,000 (the “Closing Cash Payment”); and (iii) promissory notes to be issued by the Company to the Sellers in the aggregate principal amount of US$5,000,000, with each of the above components subject to adjustments as set out in the Purchase Agreement. Based on the closing price of the Company’s common shares of (CAD$0.69) US$0.5071 as of August 25, 2023 on the Canadian Securities Exchange (the “CSE”) (based on the Bank of Canada CAD to USD exchange rate on August 25, 2023 of CAD$1.00=US$1.3606), the total consideration was valued at approximately US$48.9 million at that time. The Purchase Agreement contemplates that VidaCann will continue to have US$3,000,000 of bank indebtedness and US$1,500,000 or less of related party notes to former VidaCann owners at the Closing.


The Purchase Agreement contains customary representations, warranties and covenants. The Sellers and VidaCann have agreed to use commercially reasonable efforts to operate their business in the ordinary course consistent with past practice prior to the Closing and to refrain from taking certain actions without the Company's consent. The parties have each agreed to use their respective reasonable best efforts to consummate the transaction, including to obtain required regulatory approvals and certain consents.


The Purchase Agreement contains customary termination provisions, including the ability to terminate in the event the transaction has not been completed by April 30, 2024.

 

 

 

 

 

 

 

 

13

Exhibit 99.2

 

 

 

 

 

 

 

 

 

 

 

Financial Statements

 

VIDACANN, LLC

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ex_632134img001.jpg

 

 

 

 

 

 

 

 

 

TABLE OF CONTENTS

       
       
     

Page

     

Number

       
       

INDEPENDENT AUDITOR'S REVIEW REPORT

 

1

       
       

FINANCIAL STATEMENTS

   
       
 

Balance Sheets - March 31, 2024 and December 31, 2023

 

2

       
 

Statements of Operations - Three months ended March 31, 2024 and 2023

 

3

       
 

Statement of Changes in Members' Equity -Three months ended March 31, 2024 and the year ended December 31, 2023

 

4

       
 

Statement of Cash Flows - Three months ended March 31, 2024 and 2023

 

5

       

NOTES TO FINANCIAL STATEMENTS

 

6 - 13

 

 

 

 

 
ex_632134img001.jpg

Steven D. Rawlins, CPA

Gary M. Huggett, CPA

David W. Howie, CPA

INDEPENDENT AUDITOR'S REPORT

 

To Management and the Members

Vidacann, LLC

St Johns, Florida

 

Results of Review of Interim Financial Information

 

We have reviewed the accompanying financial statements of Vidacann, LLC., which comprise the balance sheet as of March 31, 2024, and the related statements of operations and members equity and cash flows for the three months ended March 31, 2024 and 2023, and the related notes to the financial statements (collectively referred to as the interim financial information).

 

Based on our review, we are not aware of any material modifications that should be made to the accompanying interim financial information for it to be in accordance with accounting principles generally accepted in the United States of America.

 

Basis for Review Results

 

We conducted our review in accordance with auditing standards generally accepted in the United States of America (GAAS) applicable to reviews of interim financial information. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. A review of interim financial information is substantially less in scope than an audit conducted in accordance with GAAS, the objective of which is an expression of an opinion regarding the financial information as a whole, and accordingly, we do not express such an opinion. We are required to be independent of Vidacann, LLC. and to meet our ethical responsibilities in accordance with relevant ethical requirements related to our review. We believe that the results of the review procedures provide a reasonable basis for our conclusion.

 

Responsibilities of Management for the Interim Financial Information

 

Management is responsible for the preparation and fair presentation of the interim financial information in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and presentation of financial statements that are free from material misstatement, whether due to fraud or error.

 

Report on Balance Sheet as of December 31, 2023

 

We have previously audited, in accordance with auditing standards generally accepted in the United States of America, the balance sheet as of December 31, 2023, and the related statements of operations, changes in members equity, and cash flows for the year then ended (not presented herein); and we expressed an unmodified audit opinion on those audited financial statements in our report dated April 15, 2024. In our opinion, the accompanying balance sheet of Vidacann, LLC as of December 31, 2023, is consistent, in all material respects, with the audited financial statements from which it was derived.

 

/s/ Masters, Smith & Wisby P.A.

 

Certified Public Accountants

 

Jacksonville, Florida

 

July 11, 2024

 

 

 

 

 

Jacksonville Office

4651 Salisbury Road, Suite 185

Jacksonville, FL 32256

P 904.396.2202 F 904.398.1315

www.mswcpa.com

 

 

 

1

Ponte Vedra Office

822 A1A North, Suite 310

Ponte Verda Beach, FL 32082

P 904.280.5400 F 904.247.1665

www.mswcpa.com

Members of the American and Florida Institutes of Certified Public Accountants

 

VIDACANN, LLC.

 

BALANCE SHEET

 

ASSETS

         
   

(Reviewed)

   

(Audited)

 
   

March 31, 2024

   

December 31, 2023

 
                 

Current Assets:

               

Cash and cash equivalents

  $ 5,638,045     $ 2,477,687  

Inventory

    5,314,502       5,351,599  

Capitalized cultivation costs

    1,081,926       1,985,854  

Prepaid expenses

    124,056       124,056  

Total Current Assets

    12,158,529       9,939,196  
                 

Property and Equipment:

               

Leasehold improvements

    14,756,785       14,731,111  

Machinery, equipment and vehicles

    6,867,001       6,625,701  

Furniture and fixtures

    523,072       523,072  

Computer equipment and software

    276,829       271,796  

Construction in progress

    74,682       74,682  
      22,498,369       22,226,362  

Accumulated depreciation

    (5,025,117 )     (4,693,044 )

Total Property and Equipment

    17,473,252       17,533,318  
                 

Other Assets:

               

Operating lease right-of-use assets

    20,013,366       20,874,473  

Intangible assets - net

    81,081       81,081  

Deposits and other assets

    413,549       386,722  

Total Other Assets

    20,507,996       21,342,276  
                 

Total Assets

  $ 50,139,777     $ 48,814,790  
                 

LIABILITIES AND MEMBERS' EQUITY

         
                 

Current Liabilities:

               

Accounts payable

  $ 630,883     $ 689,115  

Accrued expenses

    772,687       357,795  

Line of credit

    2,981,752       2,979,742  
Due to investors     694,481       -    

Current portion of long-term debt and finance leases

    179,444       74,339  

Current portion of operating lease liabilities

    4,059,772       4,107,362  

Total Current Liabilities

    9,319,019       8,208,353  
                 

Long-Term Liabilities:

               

Long-term debt and finance leases

    191,229       110,629  

Operating lease liabilities, less current portion

    16,147,166       16,950,911  

Due to investors

    1,500,000       2,194,481  

Total Long-Term Liabilities

    17,838,395       19,256,021  
                 

Total Liabilities

    27,157,414       27,464,374  
                 

Members' Equity

    22,982,363       21,350,416  
                 

Total Liabilities and Members' Equity

  $ 50,139,777     $ 48,814,790  
 

See Accompanying Notes to the Financial Statements

2

 

VIDACANN, LLC

 

STATEMENTS OF OPERATIONS

 

   

(Reviewed)

   

(Reviewed)

 
   

Three months ended

   

Three months ended

 
   

March 31, 2024

   

March 31, 2023

 
                 

Net Sales

  $ 12,511,055     $ 7,643,561  
                 

Cost of Goods Sold

    6,939,022       5,476,683  
                 

Gross Profit

    5,572,033       2,166,878  
                 
                 

Selling, General and Administrative Expenses:

               

Salaries, wages and related payroll expenses

    4,230,262       3,624,136  

Rent

    1,119,652       1,042,366  

Cultivation/branding fees

    131,537       138,015  

Packaging and supplies

    1,544,213       1,269,298  

Advertising

    44,312       154,195  

Automobile

    60,417       51,114  

Depreciation

    311,351       283,799  

Employee benefits

    127,009       133,200  
Contributions     1,743       525  

Commissions

    -       82,942  

Insurance

    135,923       181,525  

Outside services

    39,893       58,077  

Professional fees

    25,423       144,494  

Office expense

    218,853       179,491  

Taxes

    146,848       53,018  

Amortization

    22,942       31,241  

Retail expense

    20,950       11,346  

Product testing

    232,983       222,461  
Royalties     2,505       -  

Travel

    27,771       54,011  

Utilities

    251,207       263,718  

Repairs

    103,161       186,722  
                 

Total Selling, General and Administrative Expenses

    8,798,955       8,165,694  
                 

Applied overhead costs

    (5,477,971 )     (4,348,992 )
                 

Operating Income (Loss)

    2,251,049       (1,649,824 )
                 

Other Income (Expense):

               

Loss on disposal of property and equipment

    (1,981 )     (64,264 )

Interest expense

    (125,243 )     (164,045 )

Other income, net

    -       50,000  
                 

Net Income (Loss)

  $ 2,123,825     $ (1,798,133 )

 

See Accompanying Notes to the Financial Statements

3

 

VIDACANN, LLC

 

STATEMENT OF CHANGES IN MEMBERS' EQUITY

 

         

Loop's

 

Ray of

   
     

Loop's

 

Nursery &

 

Hope 4

   
     

Dispensaries

 

Greenhouses

 

Florida

 

 

     

LLC - 74%

 

Inc. - 1%

 

LLC - 25%

 

Total

                   
                   

Balance at January 1, 2023

   

$ 14,146,117

 

$ 1,952,593

 

$ 3,749,304

 

$ 19,848,014

                   

Net income

   

1,111,777

 

15,024

 

375,601

 

1,502,402

                   

Balance at December 31, 2023

   

$ 15,257,894

 

$ 1,967,617

 

$ 4,124,905

 

$ 21,350,416

                   

Balance at January 1, 2024

   

$ 15,257,894

 

$ 1,967,617

 

$ 4,124,905

 

$ 21,350,416

                   
Net income     1,571,631   21,238   530,956   2,123,825
                   

Member distributions

   

(491,878)

 

-

 

-

 

(491,878)

                   

Balance at March 31, 2024

   

$ 16,337,647

 

$ 1,988,855

 

$ 4,655,861

 

$ 22,982,363

 

See Accompanying Notes to the Financial Statements

4

 

VIDACANN, LLC

 

STATEMENT OF CASH FLOWS

 

   

(Reviewed)

   

(Reviewed)

 
   

Three months ended

   

Three months ended

 
   

March 31, 2024

   

March 31, 2023

 
                 

Cash Flows from Operating Activities:

               

Net Income

  $ 2,123,825     $ (1,798,133 )

Adjustments to reconcile net income (loss) to net cash

               

provided (used) by operating activities:

               

Depreciation

    311,351       283,799  

Amortization

    22,942       31,241  

Gain on disposal of property and equipment

    -         (64,264 )

(Increase) decrease in:

               

Inventory

    37,097       (302,442 )

Cultivation costs

    906,919       671,864  

Prepaid expenses

    -       5,032  

Other assets

    (26,827 )     30,247  

Right of use asset

    861,107       1,003,630  

Increase (decrease) in:

               

Accounts payable

    (58,232 )     288,236  

Accrued expenses

    414,892       317,007  

Operating lease liability

    (851,335 )     (1,031,627 )
                 

Net cash provided (used) by operating activities

    3,741,739       (565,410 )
                 

Cash Flows From Investing Activities:

               

Purchase of property and equipment

    (33,908 )     (246,313 )
                 

Net cash used by investing activities

    (33,908 )     (246,313 )
                 

Cash Flows from Financing Activities:

               

Member distributions

    (491,878 )        

Payments on debt and finance leases

    (55,595 )     (6,917 )
                 

Net cash used by financing activities

    (547,473 )     (6,917 )
                 

Net Increase (Decrease) in Cash and Cash Equivalents

    3,160,358       (818,639 )
                 

Cash and Cash Equivalents at Beginning of Period

    2,477,687       1,522,165  
                 

Cash and Cash Equivalents at End of Period

  $ 5,638,045     $ 703,526  
                 

Supplemental Disclosure of Cash Flow Information:

               

Cash paid during the period for interest

  $ 125,243     $ 134,045  
                 

Non-Cash Investing and Financing Information:

               
                 

Equipment acquired through finance lease

  $ 241,300     $ -  

 

See Accompanying Notes to the Financial Statements

5

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

March 31, 2024 and December 31, 2023

and for the Three Months Ended March 31, 2024 and 2023

 

A.         Summary of Significant Accounting Policies:

 

Nature of Business

 

Vidacann, LLC (the “Company”) d/b/a VidaCann is a limited liability corporation formed on June 13, 2019 and is the successor to Vidacann, Ltd. which was formed on September 5, 2017 and dissolved on June 13, 2019. The Company is licensed in the State of Florida as a Medical Marijuana Treatment Center under Florida Statue 381.986. The Company maintains cultivation facilities located in Jacksonville, FL and a manufacturing complex also located in Jacksonville. The Company operates 27 dispensaries located throughout the state of Florida.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, cash equivalents include time deposits, certificates of deposit and all highly liquid instruments with original maturities of three months or less. No such instruments were held at March 31, 2024 or December 31, 2023.

 

Fair Value of Financial Instruments

 

The carrying amounts of cash, accounts receivable, other current assets, accounts payable, accrued liabilities, and notes payable approximate fair value because of the short maturity of those instruments.

 

Inventory

 

Inventories are stated at the lower of cost or net realizable value based on their estimated value in the process from seed to finished product. Inventories of harvested plants are transferred from cultivation costs at an estimated cost based on the value of distilled oils. As the plants are processed into distilled oils, they are revalued to reflect the value added in the distillation process. A final revaluation is made as the oils are manufactured into the finished product. Unused packaging and hardware are initially valued at cost, less any reserves for obsolescence. All inventories are determined on the first in first out (“FIFO”) method of accounting.

 

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is provided principally using the straight-line method based on the following estimated useful lives of the assets:

 

 

Years

Leasehold improvements

40

Machinery and equipment

10

Vehicles

10

Furniture and fixtures

5-10

Computer equipment and software

3-10

`

Depreciation expense was $311,351 and $283,799 for the three months ended March 31, 2024 and 2023, respectively.

 

Expenditures for maintenance and repairs are charged to operations, while renewals and betterments are capitalized. The cost and associated accumulated depreciation of assets retired or disposed of are removed from the records and any resulting gain or loss is included in income.

 

6

 

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

March 31, 2024 and December 31, 2023

and for the Three Months Ended March 31, 2024 and 2023

 

A.         Summary of Significant Accounting Policies (continued):

 

Capitalized Cultivation Costs

 

The Company has adopted FASB ACC 905 “Agricultural Producers and Agricultural Cooperatives”, which prescribes that all direct and indirect costs of growing crops be capitalized and reported at the lower of cost or net realizable value.

 

Intangible Assets

 

The Company has adopted FASB ASC 350, “Intangibles-Goodwill and Other.” This statement requires that an intangible asset with a definite life be amortized over that life in a pattern that reflects the use or consumption of the asset’s economic benefits. For those assets that have no definite useful life, however, no amortization is to be recorded until the remaining useful life is no longer indefinite. Intangible assets that are thus not subject to amortization should be analyzed annually to determine if there has been an impairment of the asset’s value, i.e., whether future economic benefits associated with that asset are less than its current recorded value. If necessary, an impairment loss would then be recognized to reduce the asset’s carrying value to its current fair value.

 

Recent Accounting Pronouncements:

 

In February 2016, the FASB issued ASU No. 2016-02 Leases (Topic 842). This guidance amends existing lease standards requiring lessees to recognize a liability for what were previously defined as operating leases, an off-balance sheet item, on their balance sheets with a corresponding right to use asset. The Company adopted the requirements of the guidance effective January 1, 2022 and has elected to apply the provisions of this standard to the beginning of the period of adoption.  Comparative information has not been restated and continues to be reported under the accounting standards in effect for the prior period.

 

The lease liability is initially and subsequently recognized based on the present value of its future lease payments. The discount rate used is the U.S. Treasury par yield curve rate based on the information available at the commencement date for all leases. The right-to-use asset is subsequently measured throughout the lease term at the amount of the remeasured lease liability. Lease cost for lease payments is recognized on a straight-line basis over the lease term.

 

The Company has elected, for all underlying classes of assets, to not recognize right-to-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less at lease commencement, and do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise. The Company recognizes lease cost associated with short-term leases on a straight-line basis over the lease term.

 

Revenue Recognition

 

The Company has adopted Financial Accounting Standards Board (FASB) ASU 2014-09 Revenue from Contracts with Customers. This ASU establishes a uniform 5-step (performance obligations) process to ensure that revenues are recognized when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods and services. The standard also distinguishes the timing of revenues of those transferred at a point in time and those that are transferred over time.

 

7

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

March 31, 2024 and December 31, 2023

and for the Three Months Ended March 31, 2024 and 2023

 

A.         Summary of Significant Accounting Policies (continued):

 

The Company adopted the standard using the modified retrospective approach as allowed under the standard which allows only contracts not completed as of the date of adoption, with no restatement of comparative periods. Management has determined that the adoption of ASU 2014-09 has not significantly altered the way revenue is recognized for the Company. The company generates all its revenue from retail sales of its medical marijuana products in the State of Florida to licensed patients via its retail dispensaries. The performance obligations of these sales are satisfied at a point in time when the customer transfers the transaction price to the Company and the customer receives the product.

 

Advertising and Promotion

 

Advertising and promotion costs are charged to operations when incurred. Advertising and promotion expense were $44,312 and $154,195 for the three months ended March 31, 2024 and 2023, respectively. 

 

Income Taxes

 

The Company reports to its members their proportionate share of its modified cash basis income or loss for each tax year, with the members including that income or loss in their respective income tax returns. The Company itself is not a taxpaying entity for federal or state income tax purposes and accordingly, no income taxes have been recorded in these financial statements. The Company takes certain tax positions which it believes are adhering to the laws established by the taxing authorities taking into consideration IRS Section 280E rules. The Company doesn’t believe it has taken any uncertain tax positions which could subject it to penalties or interest; therefore, none have been accrued in the accompanying financial statements.

 

Use of Management Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as revenue and expenses recognized during the period reported, actual results could differ from those estimates.

 

Subsequent Events

 

The Company has evaluated subsequent events through the date of the Independent Auditor's Review Report, which is the date the financial statements were available to be issued.

 

B.         Inventory:

 

Inventory at March 31, 2024 and December 31, 2023 consisted of the following:

 

  March 31, 2024   December 31, 2023
       

Finish product - lab

$ 2,927,039  

 $ 2,622,300

Finish product-dispensaries

1,565,873  

2,033,173

Packaging and supplies

821,590  

696,126

       

Total Inventory

    $ 5,314,502

 

$ 5,351,599

 

8

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

March 31, 2024 and December 31, 2023

and for the Three Months Ended March 31, 2024 and 2023

 

C.         Notes Payable:

 

Notes payable consist of the following:

 

    March 31, 2024  

December 31, 2023

Notes payable to equipment finance company, payable in monthly payments of $1,976 of principle and interest at 0%, secured by related equipment, maturities through July 2026

  19,626  

22,820

         
Note payable to equipment finance company, payable in monthly payments of $6,400 of principle and interest at 8.49%, secured by related equipment, matures May 2026   146,388   162,148
    166,014  

184,968

Less current obligation

  (74,416)  

(74,339)

         

Note payable, net of current portion

 

 $  91,598

 

$ 110,629

 

Maturities of principal payment and the notes payable are as of September 30, 2023:

 

2025

$  74,416

2026

80,285

2027

11,313

 

$ 166,014

 

D.         Concentrations:

 

The Company is limited by Florida law to retail customers residing in the State of Florida who have a valid medical marijuana certificate.

 

E.         Lease Commitments:

 

The Company leases dispensary, cultivating, manufacturing facilities and vehicles under operating leases expiring in various years through 2029.  The lease cost for the three months ended March 31, 2024 and 2023 was $1,153,987 and $1,075,944, respectively. 

 

 

March 31,

2024

 

March 31,

2023

       

Operating Lease Cost – Buildings

$ 1,119,652  

 $ 1,042,306

Operating Lease Cost – Vehicles

34,335  

33,578

Total Lease Cost

    $ 1,153,987

 

$ 1,075,944

 

9

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

March 31, 2024 and December 31, 2023

and for the Three Months Ended March 31, 2024 and 2023

 

E.         Lease Commitments (continued):

 

Amounts reported in the consolidated balance sheet as of March 31, 2024 and December 31, 2023 were as follows:

 

 

March 31,

2024

 

December 31,

2023

Operating Lease ROU assets

$ 20,013,366  

 $ 20,874,473

Finance lease ROU assets- property and equipment 235,770   -

Total Lease Assets

$ 20,249,136  

$ 20,874,473

 

    

 

 

Current portion of operating lease liability $   4,059,772   $   4,107,362
Current portion of finance lease liability 105,028   -
       
Long-term portion of operating lease liability $ 16,147,166   $ 16,950,911
Long-term portion of finance lease liability 99,631   -

 

Other information related to leases as of March 31, 2024 and December 31, 2023 was as follows:

 

Supplemental cash flow information:      
Cash paid for amounts included in the measurement of lease liabilities

March 31,

2024

 

December 31,

2023

Operating cash flow from operating lease

 $ 1,078,555

  $ 4,334,074
Operating cash flow for finance leases 41,164   -
       
ROU assets obtained in exchange for lease obligations:      

Operating Leases

$  432,973

  $ 1,524,185
Finance leases 241,300   -

 

 

   
Weighted average remaining lease term:    
Operating leases 4.90 years   5.06 years
Finance leases 1.75 years   -
       
Weighted average discount rate:     
Operating leases 1.29%   1.29%
Finance leases 27.20%   -

 

 

10

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

March 31, 2024 and December 31, 2023

and for the Three Months Ended March 31, 2024 and 2023

 

E.         Lease Commitments (continued):

 

Maturities of lease liabilities under noncancelable operating leases as of March 31, 2024 are as follows:

 

 

Operating Leases   Finance Leases

2025

$ 4,270,933

  $ 148,337

2026

4,009,340

  111,253
2027 3,908,284   -
2028 3,812,857   -
2029 2,981,522   -

Thereafter

1,926,167

  -
       
Total 20,909,103   259,590
Less inputted interest (702,165)   (54,932)
       
       

Total

$ 20,206,938

  $ 204,658

 

F.           Line of Credit:

 

The Company has a bank line of credit available for a total of $3,000,000 secured by a blanket lien on business assets. This line of credit requires monthly interest payments at the WSJ Prime Rate plus 1.5% (10.00% at March 31, 2024). The line of credit is payable on demand and expires February 20, 2025.

 

G.           Related Party Transactions:

 

Due to Investors

 

The Company has amounts due to three investors totaling $2,194,481, at March 31, 2024 and December 31, 2023 with interest ranging from 7.5% to 10% payable monthly. 

 

Purchases

 

The Company’s vendor for certain packaging supplies is owned by an investor. The Company incurred expenses of $173,337 and $44,127 for the three months ended March 31, 2024 and 2023, respectively.

 

Cultivation facility/land lease

 

In May of 2020, the Company entered into a land lease agreement for its cultivation facility with a member which calls for rent of $300,000 per year, per greenhouse not to exceed $4,000,000 per year. This agreement expires on December 31, 2029 with renewal options for two successive periods of five years each. The Company operates nine greenhouses, the minimum rent payments for the greenhouses are included in the schedule of lease payments at Note E.

 

 

 

11

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

March 31, 2024 and December 31, 2023

and for the Three Months Ended March 31, 2024 and 2023

 

G.         Related Party Transactions (continued):

 

Manufacturing facility lease

 

The Company leases its manufacturing facility under a ten -year lease agreement with an investor expiring on April 30, 2028. The initial base rent of $126,000 per year, plus additional amounts for insurance, taxes and common area maintenance and base rent increases of 3% per year. Rent expense related to this lease was $36,517 and $35,454 for the three months ended March 31, 2024 and 2023, respectively. Future minimum lease payments are included in the schedule of lease payments at Note E.

 

H.         Concentrations of Credit Risk:

 

Cash balances are exposed to credit risk since the company periodically maintains balances in excess of FDIC insurance limits. The Company maintains its cash balances at a high-quality financial institution and does not believe it is exposed to any significant risk with respect to these cash balances. At March 31, 2024 cash balances exceed FDIC insured limits by $4,602,297.

 

I.           Retirement Plan

 

The Company has adopted a qualified 401(k) deferred compensation plan. Employees meeting certain eligibility requirements can participate in the plan by making elective salary deferrals up IRS limits. The plan provides for discretionary employer contributions as determined by management. The Company did not make any elective contributions to the plan for the three months ended March 31, 2024 and 2023, respectively.

 

J.         Membership Interest Purchase Agreement

 

On August 28, 2023, the Company and it’s members (the “Sellers”) entered into a Membership Interest Purchase Agreement (“Purchase Agreement”) with Planet 13 Holdings, Inc. (Planet 13) pursuant to which, upon the terms and subject to the conditions, Planet 13 will acquire from the Sellers all of the membership interests in VidaCann.

 

Pursuant to the Purchase Agreement, the Planet 13 will acquire VidaCann from the Sellers for agreed consideration at closing of the transaction (the “Closing”) equal to the sum of: (i) 78,461,538 shares of common stock of the Planet 13 (the “Base Share Consideration”), of which 1,307,698 shares will be issued to VidaCann’s industry advisor (the “VC Advisor”); (ii) a cash payment of US$4,000,000 (the “Closing Cash Payment”); and (iii) promissory notes to be issued by the Company to the Sellers in the aggregate principal amount of US$5,000,000, with each of the above components subject to adjustments as set out in the Purchase Agreement. Based on the closing price of the Company’s common shares of (CAD$0.69) US$0.5071 as of August 25, 2023 on the Canadian Securities Exchange (the “CSE”) (based on the Bank of Canada CAD to USD exchange rate on August 25, 2023 of CAD$1.00=US$1.3606), the total consideration was valued at approximately US$48.9 million at that time. The Purchase Agreement contemplates that VidaCann will continue to have US$3,000,000 of bank indebtedness and US$1,500,000 or less of related party notes to former VidaCann owners at the Closing.

 

 

12

VIDACANN, LLC

 

NOTES TO FINANCIAL STATEMENTS

March 31, 2024 and December 31, 2023

and for the Three Months Ended March 31, 2024 and 2023

 

J.         Membership Interest Purchase Agreement (continued):

 

The Purchase Agreement contains customary representations, warranties and covenants. The Sellers and VidaCann have agreed to use commercially reasonable efforts to operate their business in the ordinary course consistent with past practice prior to the Closing and to refrain from taking certain actions without the Company’s consent. The parties have each agreed to use their respective reasonable best efforts to consummate the transaction, including to obtain required regulatory approvals and certain consents.

 

This transaction was completed on May 9, 2024.

 

K.         Subsequent Events

 

The Company's biennial license renewal for the period July 24, 2024 to July 24, 2026 was approved by the Florida Department of Health letter dated July 8, 2024. The Company paid a fee of $1,332,124.

 

During the 2nd quarter of 2024 the Company made member distributions of $1,360,151 and paid down investor loans of $694,481.

 

 

 

 

13

Exhibit 99.4

 

 

Planet 13 Holdings Inc.

Unaudited Pro Forma Condensed Combined

Financial Statements

 

As of March 31, 2024

(Unaudited and Expressed in United States dollars)

 

 

The unaudited pro forma condensed combined financial statements of Planet 13 Holdings Inc. (“Planet 13” or the “Company”) consist of a condensed combined balance sheet at March 31, 2024, and condensed combined statements of operations and comprehensive loss for the three months ended March 31, 2024 and the year ended December 31, 2023, all of which reflect the Company’s acquisition of VidaCann LLC (“VidaCann”) and the disposition of Planet 13 Florida Inc. (“P13 Florida”) (such acquisition and disposition referred to herein as the “Transactions”). The unaudited pro forma condensed combined financial statements included herein have been derived from the following historical financial statements:

 

 

The audited consolidated financial statements of Planet 13 as at and for the year ended December 31, 2023;

 

The audited financial statements of VidaCann as at and for the year ended December 31, 2023;

 

The unaudited interim condensed consolidated financial statements of Planet 13 as at and for the three-month period ended March 31, 2024; and,

 

The unaudited interim condensed financial statements of VidaCann as at and for the three-month period ended March 31, 2024.

 

The unaudited pro forma condensed combined financial statements should be read in conjunction with the related notes, which are included herein, the financial statements and notes included in Planet 13’s Annual Report on Form 10-K for the year ended December 31, 2023, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, and the financial statements and notes of VidaCann attached as Exhibits 99.1 and 99.2 in Planet 13’s Current Report on Form 8-K filed by Planet 13 on July 24, 2024.

 

The unaudited pro forma condensed combined financial statements are presented for illustrative purposes only and do not necessarily reflect what the combined financial condition and results of operations would have reflected had the Transactions occurred on the dates indicated. They also may not be useful in predicting the future financial condition and results of the operations of the combined company. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors.

 

The unaudited pro forma information and adjustments are based upon current available information and certain assumptions that we believe are reasonable in the circumstances, as described in the notes to the unaudited pro forma condensed combined financial statements. The actual adjustments to Planet 13’s consolidated financial statements recorded upon approval of the Transaction will likely differ from those recorded in the unaudited pro forma condensed combined financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Planet 13 Holdings Inc.

 

Pro forma Consolidated Financial Statements

 

 

March 31, 2024

 

(Unaudited and Expressed in United States dollars)

 

 

 

 

 

 

 

 

 

 

 

 

PLANET 13 HOLDINGS INC.

PRO FORMA CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

AS AT MARCH 31, 2024

(EXPRESSED IN UNITED STATES DOLLARS

 

 

   

Planet 13 Holdings Inc.

 

VidaCann LLC

 

Note

Adjustments

 

Consolidated

   

$

 

$

   

$

 

$

ASSETS

                 

Current

                 
                   

Cash

 

20,771,317

 

5,638,045

 

5 (a)

(1,899,489)

   
           

5 (b)

(1,332,124)

   
           

5 (c)

(694,481)

   
           

5 (d)

(356,807)

   
           

5 (e)

(84,462)

   
           

5 (f)

(4,000,000)

   
           

5 (g)

9,000,000

   
           

5 (g)

(662,091)

 

26,379,908

Restricted Cash

 

2,050,584

       

-

 

2,050,584

Assets held for sale (P13 Florida license)

 

9,000,000

     

5 (g)

(9,000,000)

 

-

Accounts Receivable

 

1,035,465

 

-

   

-

 

1,035,465

Inventory

 

16,998,825

 

6,396,428

   

-

 

23,395,253

Prepaid expenses and Other Current Assets

 

2,893,277

 

124,056

 

5 (b)

1,332,124

 

4,349,457

   

52,749,468

 

12,158,529

   

(7,697,330)

 

57,210,667

Long-term

                 

Property and Equipment

 

67,342,325

 

17,473,252

   

-

 

84,815,577

Intangible Assets and goodwill

 

15,253,797

 

81,081

 

5 (j)

42,337,612

 

57,672,490

Right of Use Assets - operating

 

20,516,518

 

20,013,366

   

-

 

40,529,884

Long-term Deposits and Other Assets

 

800,757

 

413,549

   

-

 

1,214,306

Deferred Tax Assets

 

725,196

 

-

   

-

 

725,196

                   

Total assets

 

157,388,061

 

50,139,777

   

34,640,282

 

242,168,120

                   

LIABILITIES AND SHAREHOLDERS' EQUITY

                 

Current Liabilities

                 

Accounts Payable

 

1,953,157

 

630,883

 

5 (d)

(356,807)

 

2,227,233

Accrued Expenses

 

5,187,413

 

772,687

   

-

 

5,960,100

Income Tax Payable

 

7,499,412

 

-

   

-

 

7,499,412

Notes Payable - Current Portion

 

884,000

 

3,056,168

 

5 (i)

5,000,000

   
           

5 (e)

(84,462)

 

8,855,706

Operating Lease Liabilities

 

779,389

 

4,164,800

   

-

 

4,944,189

   

16,303,371

 

8,624,538

   

4,558,731

 

29,486,640

Long-term Liabilities

                 

Operating Lease Liabilities

 

25,801,491

 

16,246,797

   

-

 

42,048,288

Long-term debt

 

-

 

91,598

   

-

 

91,598

Due to Members

 

-

 

2,194,481

 

5 (c)

(694,481)

 

1,500,000

Other Long-term Liabilities

 

33,000

 

-

   

-

 

33,000

Deferred tax Liability

 

3,510,826

 

-

   

-

 

3,510,826

                   

Total Liabilities

 

45,648,688

 

27,157,414

   

3,864,250

 

76,670,352

                   

Shareholders' Equity

                 

Common Stock , no par value, 1,500,000,000 shares authorized, 222,247,854 issued and outstanding at Sept 30, 2023

-

 

-

   

-

 

-

Preferred Stock , no par value, 50,000,000 shares authorized, 0 issued and outstanding at March 31, 2024

-

 

-

   

-

 

-

Member's Equity

 

-

 

22,982,363

 

5 (a)

(21,082,874)

 

-

Payment to Members pre-closing

         

5 (a)

(1,899,489)

   

Additional Paid-in Capital

 

325,923,704

 

-

 

5 (h)

54,420,486

 

380,344,190

Deficit

 

(214,184,331)

 

-

 

5 (g)

(662,091)

 

(214,846,422)

                   

Total Shareholders' Equity

 

111,739,373

 

22,982,363

   

30,776,032

 

165,497,768

                   

Total Liabilities and Shareholders' Equity

 

157,388,061

 

50,139,777

   

34,640,282

 

242,168,120

                   
                   

The accompanying notes are an integral part of the financial statements.

 

 

2

PLANET 13 HOLDINGS INC.

PRO FORMA CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

FOR THE THREE MONTHS ENDED MARCH 31, 2024

(EXPRESSED IN UNITED STATES DOLLARS

 

   

Planet 13 Holdings Inc.

 

VidaCann LLC

       

Consolidated

   

Three Months Ended

 

Three Months Ended

       

Three Months Ended

   

31-Mar-24

 

31-Mar-24

 

Note

Adjustments

 

31-Mar-24

   

$

 

$

         

Revenue, net of discounts

 

22,877,471

 

12,511,055

   

-

 

35,388,526

Cost of Goods Sold

 

(12,392,992)

 

(6,939,022)

   

-

 

(19,332,014)

Gross Profit

 

10,484,479

 

5,572,033

   

-

 

16,056,512

                   

Expenses

                 

General and Administrative

 

10,024,787

 

1,822,727

   

-

 

11,847,514

Sales and Marketing

 

1,290,737

 

44,312

   

-

 

1,335,049

Lease Expense

 

774,946

 

1,119,652

   

-

 

1,894,598

Depreciation

 

2,059,023

 

334,293

   

-

 

2,393,316

                   

Total Expenses

 

14,149,493

 

3,320,984

   

-

 

17,470,477

                   

Income (Loss) from Operations

 

(3,665,014)

 

2,251,049

   

-

 

(1,413,965)

                   

Other Income (Expense):

                 

Interest Income (expense), Net

 

24,562

 

(125,243)

   

-

 

(100,681)

Foreign exchange gain/(loss)

 

(3,097)

 

-

   

-

 

(3,097)

Loss on Sale of Equipment

 

-

 

(1,981)

   

-

 

(1,981)

Other income, net

 

113,749

 

-

   

-

 

113,749

Total Other Income

 

135,214

 

(127,224)

   

-

 

7,990

                   

Income (Loss) Before Provision for Income Taxes

 

(3,529,800)

 

2,123,825

   

-

 

(1,405,975)

                   

Provision For Income Taxes

                 

Current Tax Expense

 

(2,363,860)

 

-

 

7

(1,170,127)

 

(3,533,987)

Deferred Tax Recovery

 

19,891

 

-

   

-

 

19,891

   

(2,343,969)

 

-

   

(1,170,127)

 

(3,514,096)

                   
                   

Net Income (Loss) and Comprehensive Income (Loss)

 

(5,873,769)

 

2,123,825

   

(1,170,127)

 

(4,920,071)

                   

Basic and diluted loss per share

 

(0.03)

 

-

       

(0.02)

                   
                   

Weighted Average Number of shares of Common Stock

                 

Basic and Diluted

 

228,437,545

     

6

81,872,252

 

310,309,797

                   

The accompanying notes are an integral part of the financial statements.

 

3

PLANET 13 HOLDINGS INC.

PRO FORMA CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

FOR THE YEAR ENDED DECEMBER 31, 2023

(EXPRESSED IN UNITED STATES DOLLARS

 

   

Planet 13 Holdings Inc.

 

VidaCann LLC

       

Consolidated

   

Amended & Restated

Year Ended

 

Year Ended

       

Year Ended

   

31-Dec-23

 

31-Dec-23

 

Note

Adjustments

 

31-Dec-23

   

$

 

$

         

Revenue, net of discounts

 

98,505,170

 

34,263,343

   

-

 

132,768,513

Cost of Goods Sold

 

(53,682,026)

 

(21,688,917)

   

-

 

(75,370,943)

Gross Profit

 

44,823,144

 

12,574,426

   

-

 

57,397,570

                   

Expenses

                 

General and Administrative

 

42,421,172

 

7,318,921

   

-

 

49,740,093

Sales and Marketing

 

5,368,473

 

398,955

   

-

 

5,767,428

Lease Expense

 

3,105,996

 

4,307,052

   

-

 

7,413,048

Impairment Loss

 

46,846,866

 

-

   

-

 

46,846,866

Depreciation

 

8,180,465

 

1,287,749

   

-

 

9,468,214

                   

Total Expenses

 

105,922,972

 

13,312,677

   

-

 

119,235,649

                   

Income (Loss) from Operations

 

(61,099,828)

 

(738,251)

   

-

 

(61,838,079)

                   

Other Income (Expense):

                 

Interest Income (Expense), Net

 

195,722

 

(537,774)

   

-

 

(342,052)

Foreign exchange gain/(loss)

 

3,653

 

-

   

-

 

3,653

Change in fair value of warrant liability

 

18,127

 

-

   

-

 

18,127

Gain on Sale-Leaseback

 

-

 

-

   

-

 

-

Provision for misappropriated funds

 

(2,000,000)

 

-

   

-

 

(2,000,000)

Gain on Sale of Equipment

 

-

 

(69,837)

   

-

 

(69,837)

Other income, net

 

807,023

 

2,848,264

   

-

 

3,655,287

Total Other Income (Loss)

 

(975,475)

 

2,240,653

   

-

 

1,265,178

                   

Income (Loss)  Before Provision for Income Taxes

 

(62,075,303)

 

1,502,402

   

-

 

(60,572,901)

                   

Provision For Income Taxes

                 

Current Tax Expense

 

(9,868,881)

 

-

 

7

(2,640,629)

 

(12,509,510)

Deferred Tax Recovery

 

(1,664,574)

 

-

   

-

 

(1,664,574)

   

(11,533,455)

 

-

   

(2,640,629)

 

(14,174,084)

                   
                   

Net Income (Loss) and Comprehensive Income (Loss)

 

(73,608,758)

 

1,502,402

   

(2,640,629)

 

(74,746,985)

                   

Basic and diluted loss per share

 

(0.33)

 

-

       

(0.25)

                   
                   

Weighted Average Number of shares of Common Stock

                 

Basic and Diluted

 

221,964,287

 

-

 

6

81,872,252

 

303,836,539

                   

The accompanying notes are an integral part of the financial statements.

 

4

PLANET 13 HOLDINGS INC.

NOTES TO THE PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

AS OF MARCH 31, 2024

(EXPRESSED IN UNITED STATES DOLLARS

 

1.

DESCRIPTION OF BUSINESS

 

The accompanying unaudited pro forma condensed consolidated financial statements of Planet 13 Holdings Inc. (“Planet 13” or the “Company”) have been prepared to give effect to a transaction between Planet 13 and VidaCann LLC (“VidaCann”).

 

Planet 13 was originally incorporated under the Canada Business Corporations Act on April 26, 2002, and continued under the British Columbia Business Corporations Act on September 24, 2019.

 

On September 15, 2023 (the “Effective Date”), Planet 13 Holdings Inc., a British Columbia corporation (“Planet 13 BC”) filed articles of domestication and articles of incorporation with the Secretary of State of the State of Nevada and changed its jurisdiction from the Province of British Columbia, Canada, to the State of Nevada (the “Domestication”), pursuant to a court-approved plan of arrangement (“Plan of Arrangement”).

 

On the Effective Date, pursuant to the Plan of Arrangement and by operation of law, all the rights, privileges and powers of Planet 13 BC, all property owned by Planet 13 BC, all debt due to Planet 13 BC, and all other causes of action belonging to Planet 13 BC immediately prior to the Effective Date remain vested in, or attached to, the Company following the Effective Date.

 

On the Effective Date, each holder of issued and outstanding common share of Planet 13 BC (the “Common Shares”) was deemed to receive one share of common stock of the Company (“Common Stock”), without any action required on the part of the holder thereof. Additionally, each holder of outstanding options to purchase Common Shares was deemed to receive options to purchase an equal number of shares of Common Stock at the same exercise price per share and otherwise the same terms under the Planet 13 Holdings Inc. 2018 Stock Option Plan, and each holder of restricted share units was deemed to receive restricted share units for an equal number of shares of the Common Stock and otherwise with the same terms and conditions under the Planet 13 Holdings Inc. 2018 Share Unit Plan.

 

Planet 13 common stock is listed on the Canadian Securities Exchange (“CSE”) under the ticker “PLTH” and is quoted on the OTCQX under the symbol “PLNH”.

 

VidaCann is a limited liability corporation formed on June 13, 2019, and is the successor to VidaCann, Ltd. which was formed on September 5, 2017, and dissolved on June 13, 2019. VidaCann is licensed in the State of Florida as a Medical Marijuana Treatment Center under Florida Statute 381.986. VidaCann maintains cultivation facilities located in Jacksonville, FL and a manufacturing complex also located in Jacksonville. VidaCann operates 27 dispensaries located throughout the state of Florida.

 

2.

SIGNIFICANT ACCOUNTING POLICIES

 

These unaudited pro forma consolidated financial statements have been compiled using the significant accounting policies as set out in the audited consolidated financial statements of Planet 13 as of December 31, 2023. Management has determined that no material pro forma adjustments are necessary to conform the VidaCann accounting policies to the accounting policies used by Planet 13 in the preparation of its audited financial statements.

 

3.

BASIS OF PRESENTATION

 

These unaudited pro forma consolidated financial statements have been prepared by the management of Planet 13 in connection with the transaction described in Note 4, as of March 31, 2024.

 

The pro forma consolidated financial statements have been compiled from the following financial statements and should be read in conjunction with the following financial statements:

 

5

PLANET 13 HOLDINGS INC.

NOTES TO THE PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

AS OF MARCH 31, 2024

(EXPRESSED IN UNITED STATES DOLLARS

 

 

The audited financial statements of Planet 13 as at and for the year ended December 31, 2023;

 

The audited financial statements of VidaCann as at and for the period ended December 31, 2023;

 

The unaudited interim condensed financial statements of Planet 13 as at and for the three months ended March 31, 2024; and,

 

The unaudited interim condensed financial statements of VidaCann as at and for the three months ended March 31, 2024.

 

For the pro forma consolidated statements of comprehensive income (loss) for the three months ended March 31, 2024, Planet 13 has utilized the unaudited interim condensed financial statements of VidaCann as at and for the three months ended March 31, 2024, as it is the most current information available.

 

These unaudited pro forma consolidated financial statements are not necessarily indicative of the Company's financial position on closing of the proposed transaction. In preparing these unaudited pro forma consolidated financial statements, no adjustments have been made to reflect additional costs or savings that could result from the transaction described in Note 4. Actual amounts recorded at the closing of the transaction will likely differ from those recorded in the unaudited pro forma consolidated financial statements.

 

The accompanying unaudited pro forma consolidated financial statements of the Company have been prepared by management from information derived from the financial statements, which were prepared in accordance with US GAAP Reporting Standards (“US GAAP”), of Planet 13 and VidaCann to show the effect of the transaction as discussed in Note 4.

 

4.

TRANSACTION

 

On August 28, 2023, Planet 13 and VidaCann entered into a binding Membership Interest Purchase Agreement (the “Purchase Agreement”).

 

Pursuant to the Purchase Agreement, the Company acquired VidaCann from the Sellers for agreed consideration of: (i) 81,872,252 common shares in the capital of the Company (the “Share Consideration”) issued on May 10, 2024 on closing of the transaction (78,461,538 common shares pursuant to the Purchase Agreement, adjusted to reflect additional shares issued for closing working capital balances); (ii) a cash payment of US$4,000,000 (the “Closing Cash Payment”), subject to adjustments as set out in the Purchase Agreement; and (iii) promissory notes issued by the Company to the Sellers in the aggregate principal amount of US$5,000,000, subject to adjustments as set out in the Purchase Agreement. On May 9, 2024, the closing price of Planet 13 common stock was US$0.6647 (as quoted on the Canadian Securities Exchange and converted to USD at the Bank of Canada CAD/USD exchange rate in effect as of May 9, 20240, the total consideration is valued at approximately US$63,420,486. The Purchase Agreement contemplated that VidaCann will continue to have US$3,000,000 of bank notes and US$1,500,000 or less of related party notes payable to former VidaCann owners at the time of closing. The final determination of the consideration transferred and the related allocation of the fair value of the underlying net assets of VidaCann pursuant to the transaction are yet to be fully determined.

 

Post-transaction, the former equity holders of VidaCann, along with the VC Advisor, hold approximately 23.7% pro forma ownership of Planet 13 on a fully diluted basis. All shares issued by the Company are subject to resale restrictions under applicable U.S. and Canadian securities laws. Furthermore, each Seller or equity holder of a Seller that holds over 5% in indirect interest in VidaCann and received shares is subject to a lock-up agreement restricting trading of the shares received, with the release of one-third of shares from such restrictions six months following closing and on the same date in each subsequent six months thereafter. The transaction closed on May 10, 2024, after receiving approval from the applicable state cannabis regulators. The Company also completed the divestiture of its Florida Medical Marijuana Treatment Center license on May 6, 2024, prior to closing the transaction.

 

The Sellers were granted the right on closing to nominate one additional (fifth) director to the board of directors of Planet 13 (the “Board”) and David Loop was appointed to the Company’s Board of Directors on June 12, 2024.

 

6

PLANET 13 HOLDINGS INC.

NOTES TO THE PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

AS OF MARCH 31, 2024

(EXPRESSED IN UNITED STATES DOLLARS

 

5.

PRO FORMA ASSUMPTIONS AND ADJUSTMENTS

 

The unaudited pro forma condensed consolidated statement of financial position reflects the following adjustments as if the Transactions had occurred on March 31, 2024. The unaudited pro-forma condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2023, and for the three months ended March 31, 2024 reflect the following adjustments as if the acquisition had occurred on January 1, 2023 and January 1, 2024 respectively.

 

The unaudited pro forma consolidated financial statements have been presented giving effect to the following assumptions and pro forma adjustments:

 

 

a)

A reduction in share capital of $21,082,874 after reflecting a cash distribution to members of $1,899,489, to eliminate VidaCann's historical Members Equity,

 

b)

Payment of the 2024 VidaCann license renewal fee of $1,332,124 prior to closing

 

c)

A reduction of the related party debt due to VidaCann members of $694,481 to reduce the balance to $1,500,000 on closing.

 

d)

A reduction in accounts payable of $356,807 based on the estimated balance on closing.

 

e)

A reduction in notes payable to a third-party bank by $84,462 to reflect the balance of the notes on closing.

 

f)

An adjustment of $4,000,000 to the consolidated cash balance representing a $4,000,000 cash payment to the VidaCann Members on closing.

 

g)

An increase in cash of $9,000,000 representing the cash proceeds realized on the sale of the Planet 13 Florida Inc. MMTC license to a third party on May 6, 2024, prior to the closing of the VidaCann acquisition and a reduction in cash of $662,091 in estimated transaction costs that were expensed as part of the sale of the Planet 13 Florida license.

 

h)

An increase in Additional Paid in Capital of $54,420,486 reflects the issuance of 81,872,252 shares of Common Stock at $0.6647 per share based on the closing share price of PLTH as quoted on the CSE on May 9, 2024, converted to USD at the Bank of Canada daily exchange rate.

 

i)

An increase of $5,000,000 in Vendor Take-Back Notes issued to VidaCann Members on closing.

 

j)

To record the Transactions in accordance with ASC 805 as at March 31, 2024:

 

Planet 13 Shares of common stock issued

  81,872,252

Share price on May 9, 2024

$0.6647

Value of share consideration

$54,420,486

Cash

$4,000,000

Vendor-Take-Back Notes

$5,000,000

Total consideration

$63,420,486

   

Less: Net Book Value of VidaCann

$21,082,874

   

Estimated Goodwill

$42,337,612

 

The Company estimates that the value ascribed to intangible assets and goodwill as part of the acquisition is $42,337,612.

 

 

7

PLANET 13 HOLDINGS INC.

NOTES TO THE PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

AS OF MARCH 31, 2024

(EXPRESSED IN UNITED STATES DOLLARS

 

6.

PRO FORMA SHARES OF COMMON STOCK

 

Common Stock in the unaudited pro forma consolidated financial statements is comprised of the following:

 

   

Number of

shares

Additional Paid in

Capital

($)

Planet 13s Shares of Common Stock outstanding  March 31, 2024

 

243,291,548

325,923,704

Shares of Common stock issued to VidaCann’s Members

 

81,872,252

54,420,486

Pro forma consolidated Shares of Common Stock

 

325,163,800

380,344,190

 

7.

INCOME TAXES

 

The pro forma effective statutory income tax rate applicable to the consolidated operations subsequent to the completion of the Proposed Acquisition is approximately 21%.

 

8
v3.24.2
Document And Entity Information
May 10, 2024
Document Information [Line Items]  
Entity, Registrant Name PLANET 13 HOLDINGS INC.
Document, Type 8-K/A
Document, Period End Date May 10, 2024
Entity, Incorporation, State or Country Code NV
Entity, File Number 000-56374
Entity, Tax Identification Number 83-2787199
Entity, Address, Address Line One 2548 West Desert Inn Road, Suite 100
Entity, Address, City or Town Las Vegas
Entity, Address, State or Province NV
Entity, Address, Postal Zip Code 89109
City Area Code 702
Local Phone Number 815-1313
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company true
Entity, Ex Transition Period false
Amendment Description Form 8-K/A - Vidacann Closing
Amendment Flag true
Entity, Central Index Key 0001813452

Planet 13 (QX) (USOTC:PLNHF)
過去 株価チャート
から 6 2024 まで 7 2024 Planet 13 (QX)のチャートをもっと見るにはこちらをクリック
Planet 13 (QX) (USOTC:PLNHF)
過去 株価チャート
から 7 2023 まで 7 2024 Planet 13 (QX)のチャートをもっと見るにはこちらをクリック